Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Omnicell

Health Tech & Medtech · Mountain View, United States · Founded 1992 · IPO 2001 Unicorn

Our automated medication/supply mgmt, business analytics solutions, and adherence packaging enable improved efficiency, patient safety & satisfaction

Valuation
$1.84B
Market cap · May/2026
Revenue
$1.18B
Latest reported FY
EBITDA
$163M
Latest reported FY

Global footprint

Where Omnicell has talent and traffic

AI talent share
0.6% of workforce is AI talent
(20 of 3,380 staff)
Core AI40.12%
Other AI160.47%
Non-AI workforce3,36099.41%
Workforce by country
20 countries with
team presence
🇺🇸 United States82.5%
🇮🇳 India5.7%
🇬🇧 United Kingdom3.9%
🇫🇷 France1.9%
🇮🇹 Italy1.4%
Top 5 of 20 shown
Web traffic by country
93K monthly visits
across markets
🇺🇸 United States68.1%
🇬🇧 United Kingdom17.3%
🇨🇦 Canada7.6%
🇮🇳 India3.5%
🇳🇬 Nigeria1.9%
Top 5 markets shown

Patent intelligence

$229M patent portfolio · 143 active families

Estimated portfolio value
$229M
12.5% of market cap · 2.5× the top peer Corindus ($93M)
143 active patent families
Where Omnicell innovates Biomedical engineeringPharmaceutical drugDrugMedical treatmentComputer program

Where Omnicell concentrates vs peers

Each axis is a top-10 topic across Omnicell and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Omnicell's 6 investments and acquisitions.

Every disclosed deal where Omnicell appeared as a backer or acquirer, 2012–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Omnicell's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Omnicell deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Omnicell's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about Omnicell

        An AI-synthesized read of the highest-engagement posts about Omnicell on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Omnicell on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.